Annual CFO
-$33.45 M
-$13.05 M-64.01%
31 December 2023
Summary:
Alto Neuroscience annual cash flow from operations is currently -$33.45 million, with the most recent change of -$13.05 million (-64.01%) on 31 December 2023. ANRO annual CFO is now -261.13% below its all-time high of -$9.26 million, reached on 01 December 2021.ANRO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$11.73 M
-$32.00 K-0.27%
30 September 2024
Summary:
Alto Neuroscience quarterly cash flow from operations is currently -$11.73 million, with the most recent change of -$32.00 thousand (-0.27%) on 30 September 2024. Over the past year, it has dropped by -$3.96 million (-51.01%). ANRO quarterly CFO is now -76.73% below its all-time high of -$6.63 million, reached on 01 June 2023.ANRO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$45.93 M
-$3.96 M-9.44%
30 September 2024
Summary:
Alto Neuroscience TTM cash flow from operations is currently -$45.93 million, with the most recent change of -$3.96 million (-9.44%) on 30 September 2024. Over the past year, it has dropped by -$24.00 million (-109.48%). ANRO TTM CFO is now -510.41% below its all-time high of -$7.52 million, reached on 01 March 2023.ANRO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANRO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -64.0% | -51.0% | -109.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ANRO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -261.1% | at low | -76.7% | at low | -510.4% | at low |
| 5 y | 5 years | -261.1% | at low | -76.7% | at low | -510.4% | at low |
| alltime | all time | -261.1% | at low | -76.7% | at low | -510.4% | at low |
Alto Neuroscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.73 M(+0.3%) | -$45.93 M(+9.4%) |
| June 2024 | - | -$11.69 M(+6.5%) | -$41.97 M(+13.7%) |
| Mar 2024 | - | -$10.98 M(-4.7%) | -$36.91 M(+10.3%) |
| Dec 2023 | -$33.45 M | -$11.52 M(+48.4%) | -$33.45 M(+52.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$7.76 M(+17.0%) | -$21.92 M(+54.8%) |
| June 2023 | - | -$6.63 M(-11.8%) | -$14.16 M(+88.2%) |
| Mar 2023 | - | -$7.52 M | -$7.52 M |
| Dec 2022 | -$20.39 M(+120.2%) | - | - |
| Dec 2021 | -$9.26 M | - | - |
FAQ
- What is Alto Neuroscience annual cash flow from operations?
- What is the all time high annual CFO for Alto Neuroscience?
- What is Alto Neuroscience annual CFO year-on-year change?
- What is Alto Neuroscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for Alto Neuroscience?
- What is Alto Neuroscience quarterly CFO year-on-year change?
- What is Alto Neuroscience TTM cash flow from operations?
- What is the all time high TTM CFO for Alto Neuroscience?
- What is Alto Neuroscience TTM CFO year-on-year change?
What is Alto Neuroscience annual cash flow from operations?
The current annual CFO of ANRO is -$33.45 M
What is the all time high annual CFO for Alto Neuroscience?
Alto Neuroscience all-time high annual cash flow from operations is -$9.26 M
What is Alto Neuroscience annual CFO year-on-year change?
Over the past year, ANRO annual cash flow from operations has changed by -$13.05 M (-64.01%)
What is Alto Neuroscience quarterly cash flow from operations?
The current quarterly CFO of ANRO is -$11.73 M
What is the all time high quarterly CFO for Alto Neuroscience?
Alto Neuroscience all-time high quarterly cash flow from operations is -$6.63 M
What is Alto Neuroscience quarterly CFO year-on-year change?
Over the past year, ANRO quarterly cash flow from operations has changed by -$3.96 M (-51.01%)
What is Alto Neuroscience TTM cash flow from operations?
The current TTM CFO of ANRO is -$45.93 M
What is the all time high TTM CFO for Alto Neuroscience?
Alto Neuroscience all-time high TTM cash flow from operations is -$7.52 M
What is Alto Neuroscience TTM CFO year-on-year change?
Over the past year, ANRO TTM cash flow from operations has changed by -$24.00 M (-109.48%)